nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—CYP3A5—prostate cancer	0.2	0.698	CbGaD
Boceprevir—CYP3A4—prostate cancer	0.0866	0.302	CbGaD
Boceprevir—CYP3A5—Flutamide—prostate cancer	0.0304	0.0879	CbGbCtD
Boceprevir—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0272	0.0787	CbGbCtD
Boceprevir—CYP3A5—Cabazitaxel—prostate cancer	0.0225	0.065	CbGbCtD
Boceprevir—ABCB1—Estramustine—prostate cancer	0.0222	0.0642	CbGbCtD
Boceprevir—CYP3A5—Estrone—prostate cancer	0.022	0.0635	CbGbCtD
Boceprevir—ABCB1—Cabazitaxel—prostate cancer	0.0146	0.0423	CbGbCtD
Boceprevir—CYP3A4—Bicalutamide—prostate cancer	0.0143	0.0413	CbGbCtD
Boceprevir—ABCB1—Estrone—prostate cancer	0.0143	0.0413	CbGbCtD
Boceprevir—CYP3A4—Estramustine—prostate cancer	0.0133	0.0384	CbGbCtD
Boceprevir—ABCB1—Ethinyl Estradiol—prostate cancer	0.0127	0.0368	CbGbCtD
Boceprevir—CYP3A5—Estradiol—prostate cancer	0.0126	0.0365	CbGbCtD
Boceprevir—CYP3A4—Abiraterone—prostate cancer	0.0118	0.0343	CbGbCtD
Boceprevir—CYP3A4—Flutamide—prostate cancer	0.0118	0.0343	CbGbCtD
Boceprevir—ABCB1—Conjugated Estrogens—prostate cancer	0.00935	0.027	CbGbCtD
Boceprevir—CYP3A4—Cabazitaxel—prostate cancer	0.00876	0.0253	CbGbCtD
Boceprevir—CYP3A4—Estrone—prostate cancer	0.00856	0.0248	CbGbCtD
Boceprevir—ABCB1—Mitoxantrone—prostate cancer	0.0085	0.0246	CbGbCtD
Boceprevir—CYP3A5—Etoposide—prostate cancer	0.00824	0.0238	CbGbCtD
Boceprevir—ABCB1—Estradiol—prostate cancer	0.00821	0.0237	CbGbCtD
Boceprevir—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00763	0.0221	CbGbCtD
Boceprevir—CYP3A5—Docetaxel—prostate cancer	0.00754	0.0218	CbGbCtD
Boceprevir—ABCB1—Prednisone—prostate cancer	0.00706	0.0204	CbGbCtD
Boceprevir—CYP3A4—Conjugated Estrogens—prostate cancer	0.0056	0.0162	CbGbCtD
Boceprevir—ABCB1—Etoposide—prostate cancer	0.00536	0.0155	CbGbCtD
Boceprevir—CYP3A4—Mitoxantrone—prostate cancer	0.00509	0.0147	CbGbCtD
Boceprevir—CYP3A4—Estradiol—prostate cancer	0.00492	0.0142	CbGbCtD
Boceprevir—ABCB1—Docetaxel—prostate cancer	0.0049	0.0142	CbGbCtD
Boceprevir—CYP3A4—Prednisone—prostate cancer	0.00423	0.0122	CbGbCtD
Boceprevir—CTSV—prostate gland—prostate cancer	0.00384	0.0649	CbGeAlD
Boceprevir—CMA1—prostate gland—prostate cancer	0.00367	0.062	CbGeAlD
Boceprevir—ABCB1—Doxorubicin—prostate cancer	0.00366	0.0106	CbGbCtD
Boceprevir—CTSV—seminal vesicle—prostate cancer	0.00325	0.0549	CbGeAlD
Boceprevir—CYP3A4—Etoposide—prostate cancer	0.00321	0.00929	CbGbCtD
Boceprevir—CTSL—prostate gland—prostate cancer	0.00314	0.053	CbGeAlD
Boceprevir—CYP3A4—Docetaxel—prostate cancer	0.00294	0.0085	CbGbCtD
Boceprevir—CTSL—seminal vesicle—prostate cancer	0.00265	0.0449	CbGeAlD
Boceprevir—CTSV—renal system—prostate cancer	0.00262	0.0443	CbGeAlD
Boceprevir—CTSK—prostate gland—prostate cancer	0.00236	0.04	CbGeAlD
Boceprevir—CTSL—epithelium—prostate cancer	0.0023	0.039	CbGeAlD
Boceprevir—CYP3A4—Doxorubicin—prostate cancer	0.00219	0.00634	CbGbCtD
Boceprevir—CTSL—renal system—prostate cancer	0.00214	0.0362	CbGeAlD
Boceprevir—CTSL—urethra—prostate cancer	0.0021	0.0355	CbGeAlD
Boceprevir—CTSS—prostate gland—prostate cancer	0.00207	0.035	CbGeAlD
Boceprevir—CTSK—seminal vesicle—prostate cancer	0.002	0.0338	CbGeAlD
Boceprevir—CMA1—bone marrow—prostate cancer	0.00189	0.032	CbGeAlD
Boceprevir—CTSS—seminal vesicle—prostate cancer	0.00175	0.0296	CbGeAlD
Boceprevir—CTSV—testis—prostate cancer	0.00169	0.0286	CbGeAlD
Boceprevir—CTSL—bone marrow—prostate cancer	0.00162	0.0273	CbGeAlD
Boceprevir—CTSK—renal system—prostate cancer	0.00161	0.0272	CbGeAlD
Boceprevir—CTSK—urethra—prostate cancer	0.00158	0.0268	CbGeAlD
Boceprevir—CYP3A4—urine—prostate cancer	0.00144	0.0243	CbGeAlD
Boceprevir—CTSS—renal system—prostate cancer	0.00141	0.0239	CbGeAlD
Boceprevir—CTSS—urethra—prostate cancer	0.00139	0.0234	CbGeAlD
Boceprevir—CTSL—testis—prostate cancer	0.00138	0.0234	CbGeAlD
Boceprevir—CTSK—bone marrow—prostate cancer	0.00122	0.0206	CbGeAlD
Boceprevir—CMA1—lymph node—prostate cancer	0.00117	0.0198	CbGeAlD
Boceprevir—CTSS—bone marrow—prostate cancer	0.00107	0.018	CbGeAlD
Boceprevir—CTSK—testis—prostate cancer	0.00104	0.0176	CbGeAlD
Boceprevir—CTSL—lymph node—prostate cancer	0.001	0.0169	CbGeAlD
Boceprevir—CTSK—Estradiol—Estradiol valerate/Dienogest—prostate cancer	0.000931	0.268	CbGdCrCtD
Boceprevir—CTSS—testis—prostate cancer	0.000912	0.0154	CbGeAlD
Boceprevir—CTSK—Estradiol—Estramustine—prostate cancer	0.000791	0.228	CbGdCrCtD
Boceprevir—CTSK—lymph node—prostate cancer	0.000755	0.0128	CbGeAlD
Boceprevir—CYP3A5—prostate gland—prostate cancer	0.000688	0.0116	CbGeAlD
Boceprevir—CTSS—lymph node—prostate cancer	0.000661	0.0112	CbGeAlD
Boceprevir—Telaprevir—CYP3A4—prostate cancer	0.000632	1	CrCbGaD
Boceprevir—CTSK—Estradiol—Estrone—prostate cancer	0.000629	0.181	CbGdCrCtD
Boceprevir—CTSK—Estradiol—Conjugated Estrogens—prostate cancer	0.000553	0.16	CbGdCrCtD
Boceprevir—CYP3A5—renal system—prostate cancer	0.000469	0.00793	CbGeAlD
Boceprevir—CTSK—Estradiol—Ethinyl Estradiol—prostate cancer	0.000465	0.134	CbGdCrCtD
Boceprevir—ABCB1—prostate gland—prostate cancer	0.000365	0.00618	CbGeAlD
Boceprevir—CYP3A4—renal system—prostate cancer	0.000352	0.00595	CbGeAlD
Boceprevir—ABCB1—seminal vesicle—prostate cancer	0.000309	0.00523	CbGeAlD
Boceprevir—ABCB1—epithelium—prostate cancer	0.000268	0.00454	CbGeAlD
Boceprevir—ABCB1—renal system—prostate cancer	0.000249	0.00421	CbGeAlD
Boceprevir—ABCB1—urethra—prostate cancer	0.000245	0.00414	CbGeAlD
Boceprevir—ABCB1—bone marrow—prostate cancer	0.000188	0.00318	CbGeAlD
Boceprevir—ABCB1—testis—prostate cancer	0.000161	0.00272	CbGeAlD
Boceprevir—ABCB1—lymph node—prostate cancer	0.000117	0.00197	CbGeAlD
Boceprevir—CTSL—Dexamethasone—Prednisone—prostate cancer	4.98e-05	0.0144	CbGdCrCtD
Boceprevir—CTSL—Betamethasone—Prednisone—prostate cancer	4.98e-05	0.0144	CbGdCrCtD
Boceprevir—Visual impairment—Epirubicin—prostate cancer	2.71e-05	0.00016	CcSEcCtD
Boceprevir—Agranulocytosis—Doxorubicin—prostate cancer	2.7e-05	0.00016	CcSEcCtD
Boceprevir—Hypertension—Prednisone—prostate cancer	2.7e-05	0.000159	CcSEcCtD
Boceprevir—Rash—Mitoxantrone—prostate cancer	2.7e-05	0.000159	CcSEcCtD
Boceprevir—Dermatitis—Mitoxantrone—prostate cancer	2.7e-05	0.000159	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Docetaxel—prostate cancer	2.7e-05	0.000159	CcSEcCtD
Boceprevir—Headache—Mitoxantrone—prostate cancer	2.68e-05	0.000158	CcSEcCtD
Boceprevir—Hypotension—Capecitabine—prostate cancer	2.68e-05	0.000158	CcSEcCtD
Boceprevir—Insomnia—Docetaxel—prostate cancer	2.68e-05	0.000158	CcSEcCtD
Boceprevir—Myalgia—Prednisone—prostate cancer	2.66e-05	0.000157	CcSEcCtD
Boceprevir—Arthralgia—Prednisone—prostate cancer	2.66e-05	0.000157	CcSEcCtD
Boceprevir—Paraesthesia—Docetaxel—prostate cancer	2.66e-05	0.000157	CcSEcCtD
Boceprevir—Erythema multiforme—Epirubicin—prostate cancer	2.66e-05	0.000157	CcSEcCtD
Boceprevir—Anxiety—Prednisone—prostate cancer	2.65e-05	0.000157	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	2.64e-05	0.000156	CcSEcCtD
Boceprevir—Dyspnoea—Docetaxel—prostate cancer	2.64e-05	0.000156	CcSEcCtD
Boceprevir—Discomfort—Prednisone—prostate cancer	2.63e-05	0.000155	CcSEcCtD
Boceprevir—Eye disorder—Epirubicin—prostate cancer	2.63e-05	0.000155	CcSEcCtD
Boceprevir—Hypersensitivity—Etoposide—prostate cancer	2.62e-05	0.000155	CcSEcCtD
Boceprevir—Tinnitus—Epirubicin—prostate cancer	2.62e-05	0.000155	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.61e-05	0.000154	CcSEcCtD
Boceprevir—Cardiac disorder—Epirubicin—prostate cancer	2.61e-05	0.000154	CcSEcCtD
Boceprevir—Flushing—Epirubicin—prostate cancer	2.61e-05	0.000154	CcSEcCtD
Boceprevir—Rhinitis—Doxorubicin—prostate cancer	2.61e-05	0.000154	CcSEcCtD
Boceprevir—Dyspepsia—Docetaxel—prostate cancer	2.6e-05	0.000154	CcSEcCtD
Boceprevir—Insomnia—Capecitabine—prostate cancer	2.59e-05	0.000153	CcSEcCtD
Boceprevir—Hypoaesthesia—Doxorubicin—prostate cancer	2.59e-05	0.000153	CcSEcCtD
Boceprevir—Pharyngitis—Doxorubicin—prostate cancer	2.58e-05	0.000152	CcSEcCtD
Boceprevir—Paraesthesia—Capecitabine—prostate cancer	2.57e-05	0.000152	CcSEcCtD
Boceprevir—Decreased appetite—Docetaxel—prostate cancer	2.57e-05	0.000152	CcSEcCtD
Boceprevir—Urinary tract disorder—Doxorubicin—prostate cancer	2.57e-05	0.000152	CcSEcCtD
Boceprevir—Oedema peripheral—Doxorubicin—prostate cancer	2.56e-05	0.000151	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Docetaxel—prostate cancer	2.55e-05	0.000151	CcSEcCtD
Boceprevir—Asthenia—Etoposide—prostate cancer	2.55e-05	0.000151	CcSEcCtD
Boceprevir—Connective tissue disorder—Doxorubicin—prostate cancer	2.55e-05	0.000151	CcSEcCtD
Boceprevir—Dyspnoea—Capecitabine—prostate cancer	2.55e-05	0.000151	CcSEcCtD
Boceprevir—Fatigue—Docetaxel—prostate cancer	2.55e-05	0.000151	CcSEcCtD
Boceprevir—Angiopathy—Epirubicin—prostate cancer	2.55e-05	0.000151	CcSEcCtD
Boceprevir—Urethral disorder—Doxorubicin—prostate cancer	2.55e-05	0.000151	CcSEcCtD
Boceprevir—Nausea—Mitoxantrone—prostate cancer	2.54e-05	0.00015	CcSEcCtD
Boceprevir—Immune system disorder—Epirubicin—prostate cancer	2.54e-05	0.00015	CcSEcCtD
Boceprevir—Infection—Prednisone—prostate cancer	2.54e-05	0.00015	CcSEcCtD
Boceprevir—Mediastinal disorder—Epirubicin—prostate cancer	2.53e-05	0.00015	CcSEcCtD
Boceprevir—Constipation—Docetaxel—prostate cancer	2.53e-05	0.000149	CcSEcCtD
Boceprevir—Pain—Docetaxel—prostate cancer	2.53e-05	0.000149	CcSEcCtD
Boceprevir—Dyspepsia—Capecitabine—prostate cancer	2.52e-05	0.000149	CcSEcCtD
Boceprevir—Chills—Epirubicin—prostate cancer	2.52e-05	0.000149	CcSEcCtD
Boceprevir—Pruritus—Etoposide—prostate cancer	2.52e-05	0.000149	CcSEcCtD
Boceprevir—Shock—Prednisone—prostate cancer	2.51e-05	0.000148	CcSEcCtD
Boceprevir—Arrhythmia—Epirubicin—prostate cancer	2.51e-05	0.000148	CcSEcCtD
Boceprevir—Visual impairment—Doxorubicin—prostate cancer	2.51e-05	0.000148	CcSEcCtD
Boceprevir—Nervous system disorder—Prednisone—prostate cancer	2.5e-05	0.000148	CcSEcCtD
Boceprevir—Tachycardia—Prednisone—prostate cancer	2.49e-05	0.000147	CcSEcCtD
Boceprevir—Decreased appetite—Capecitabine—prostate cancer	2.49e-05	0.000147	CcSEcCtD
Boceprevir—Alopecia—Epirubicin—prostate cancer	2.48e-05	0.000147	CcSEcCtD
Boceprevir—Skin disorder—Prednisone—prostate cancer	2.48e-05	0.000146	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Capecitabine—prostate cancer	2.47e-05	0.000146	CcSEcCtD
Boceprevir—Fatigue—Capecitabine—prostate cancer	2.47e-05	0.000146	CcSEcCtD
Boceprevir—Hyperhidrosis—Prednisone—prostate cancer	2.47e-05	0.000146	CcSEcCtD
Boceprevir—Mental disorder—Epirubicin—prostate cancer	2.46e-05	0.000145	CcSEcCtD
Boceprevir—Erythema multiforme—Doxorubicin—prostate cancer	2.46e-05	0.000145	CcSEcCtD
Boceprevir—Constipation—Capecitabine—prostate cancer	2.45e-05	0.000145	CcSEcCtD
Boceprevir—Pain—Capecitabine—prostate cancer	2.45e-05	0.000145	CcSEcCtD
Boceprevir—Erythema—Epirubicin—prostate cancer	2.45e-05	0.000144	CcSEcCtD
Boceprevir—Malnutrition—Epirubicin—prostate cancer	2.45e-05	0.000144	CcSEcCtD
Boceprevir—Feeling abnormal—Docetaxel—prostate cancer	2.44e-05	0.000144	CcSEcCtD
Boceprevir—Diarrhoea—Etoposide—prostate cancer	2.44e-05	0.000144	CcSEcCtD
Boceprevir—Eye disorder—Doxorubicin—prostate cancer	2.43e-05	0.000144	CcSEcCtD
Boceprevir—Tinnitus—Doxorubicin—prostate cancer	2.42e-05	0.000143	CcSEcCtD
Boceprevir—Gastrointestinal pain—Docetaxel—prostate cancer	2.42e-05	0.000143	CcSEcCtD
Boceprevir—Flushing—Doxorubicin—prostate cancer	2.41e-05	0.000143	CcSEcCtD
Boceprevir—Cardiac disorder—Doxorubicin—prostate cancer	2.41e-05	0.000143	CcSEcCtD
Boceprevir—Flatulence—Epirubicin—prostate cancer	2.41e-05	0.000142	CcSEcCtD
Boceprevir—Dysgeusia—Epirubicin—prostate cancer	2.39e-05	0.000141	CcSEcCtD
Boceprevir—Back pain—Epirubicin—prostate cancer	2.37e-05	0.00014	CcSEcCtD
Boceprevir—Feeling abnormal—Capecitabine—prostate cancer	2.36e-05	0.000139	CcSEcCtD
Boceprevir—Angiopathy—Doxorubicin—prostate cancer	2.36e-05	0.000139	CcSEcCtD
Boceprevir—Dizziness—Etoposide—prostate cancer	2.35e-05	0.000139	CcSEcCtD
Boceprevir—Muscle spasms—Epirubicin—prostate cancer	2.35e-05	0.000139	CcSEcCtD
Boceprevir—Immune system disorder—Doxorubicin—prostate cancer	2.35e-05	0.000139	CcSEcCtD
Boceprevir—Gastrointestinal pain—Capecitabine—prostate cancer	2.34e-05	0.000138	CcSEcCtD
Boceprevir—Mediastinal disorder—Doxorubicin—prostate cancer	2.34e-05	0.000138	CcSEcCtD
Boceprevir—Abdominal pain—Docetaxel—prostate cancer	2.34e-05	0.000138	CcSEcCtD
Boceprevir—Body temperature increased—Docetaxel—prostate cancer	2.34e-05	0.000138	CcSEcCtD
Boceprevir—Chills—Doxorubicin—prostate cancer	2.33e-05	0.000138	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Prednisone—prostate cancer	2.33e-05	0.000137	CcSEcCtD
Boceprevir—Arrhythmia—Doxorubicin—prostate cancer	2.32e-05	0.000137	CcSEcCtD
Boceprevir—Insomnia—Prednisone—prostate cancer	2.31e-05	0.000136	CcSEcCtD
Boceprevir—Vision blurred—Epirubicin—prostate cancer	2.3e-05	0.000136	CcSEcCtD
Boceprevir—Alopecia—Doxorubicin—prostate cancer	2.3e-05	0.000136	CcSEcCtD
Boceprevir—Paraesthesia—Prednisone—prostate cancer	2.29e-05	0.000135	CcSEcCtD
Boceprevir—Mental disorder—Doxorubicin—prostate cancer	2.28e-05	0.000135	CcSEcCtD
Boceprevir—Urticaria—Capecitabine—prostate cancer	2.28e-05	0.000134	CcSEcCtD
Boceprevir—Ill-defined disorder—Epirubicin—prostate cancer	2.27e-05	0.000134	CcSEcCtD
Boceprevir—Body temperature increased—Capecitabine—prostate cancer	2.26e-05	0.000134	CcSEcCtD
Boceprevir—Abdominal pain—Capecitabine—prostate cancer	2.26e-05	0.000134	CcSEcCtD
Boceprevir—Vomiting—Etoposide—prostate cancer	2.26e-05	0.000134	CcSEcCtD
Boceprevir—Malnutrition—Doxorubicin—prostate cancer	2.26e-05	0.000134	CcSEcCtD
Boceprevir—Erythema—Doxorubicin—prostate cancer	2.26e-05	0.000134	CcSEcCtD
Boceprevir—Anaemia—Epirubicin—prostate cancer	2.26e-05	0.000134	CcSEcCtD
Boceprevir—Agitation—Epirubicin—prostate cancer	2.25e-05	0.000133	CcSEcCtD
Boceprevir—Dyspepsia—Prednisone—prostate cancer	2.25e-05	0.000133	CcSEcCtD
Boceprevir—Rash—Etoposide—prostate cancer	2.25e-05	0.000133	CcSEcCtD
Boceprevir—Dermatitis—Etoposide—prostate cancer	2.24e-05	0.000133	CcSEcCtD
Boceprevir—Headache—Etoposide—prostate cancer	2.23e-05	0.000132	CcSEcCtD
Boceprevir—Flatulence—Doxorubicin—prostate cancer	2.23e-05	0.000132	CcSEcCtD
Boceprevir—Decreased appetite—Prednisone—prostate cancer	2.22e-05	0.000131	CcSEcCtD
Boceprevir—Dysgeusia—Doxorubicin—prostate cancer	2.22e-05	0.000131	CcSEcCtD
Boceprevir—Malaise—Epirubicin—prostate cancer	2.21e-05	0.00013	CcSEcCtD
Boceprevir—Fatigue—Prednisone—prostate cancer	2.2e-05	0.00013	CcSEcCtD
Boceprevir—Vertigo—Epirubicin—prostate cancer	2.2e-05	0.00013	CcSEcCtD
Boceprevir—Syncope—Epirubicin—prostate cancer	2.19e-05	0.00013	CcSEcCtD
Boceprevir—Leukopenia—Epirubicin—prostate cancer	2.19e-05	0.000129	CcSEcCtD
Boceprevir—Back pain—Doxorubicin—prostate cancer	2.19e-05	0.000129	CcSEcCtD
Boceprevir—Constipation—Prednisone—prostate cancer	2.18e-05	0.000129	CcSEcCtD
Boceprevir—Hypersensitivity—Docetaxel—prostate cancer	2.18e-05	0.000129	CcSEcCtD
Boceprevir—Muscle spasms—Doxorubicin—prostate cancer	2.18e-05	0.000129	CcSEcCtD
Boceprevir—Palpitations—Epirubicin—prostate cancer	2.16e-05	0.000128	CcSEcCtD
Boceprevir—Loss of consciousness—Epirubicin—prostate cancer	2.15e-05	0.000127	CcSEcCtD
Boceprevir—Cough—Epirubicin—prostate cancer	2.13e-05	0.000126	CcSEcCtD
Boceprevir—Vision blurred—Doxorubicin—prostate cancer	2.13e-05	0.000126	CcSEcCtD
Boceprevir—Asthenia—Docetaxel—prostate cancer	2.12e-05	0.000125	CcSEcCtD
Boceprevir—Nausea—Etoposide—prostate cancer	2.11e-05	0.000125	CcSEcCtD
Boceprevir—Hypertension—Epirubicin—prostate cancer	2.11e-05	0.000125	CcSEcCtD
Boceprevir—Hypersensitivity—Capecitabine—prostate cancer	2.11e-05	0.000125	CcSEcCtD
Boceprevir—Feeling abnormal—Prednisone—prostate cancer	2.1e-05	0.000124	CcSEcCtD
Boceprevir—Ill-defined disorder—Doxorubicin—prostate cancer	2.1e-05	0.000124	CcSEcCtD
Boceprevir—Pruritus—Docetaxel—prostate cancer	2.09e-05	0.000124	CcSEcCtD
Boceprevir—Anaemia—Doxorubicin—prostate cancer	2.09e-05	0.000124	CcSEcCtD
Boceprevir—Gastrointestinal pain—Prednisone—prostate cancer	2.09e-05	0.000123	CcSEcCtD
Boceprevir—Chest pain—Epirubicin—prostate cancer	2.08e-05	0.000123	CcSEcCtD
Boceprevir—Myalgia—Epirubicin—prostate cancer	2.08e-05	0.000123	CcSEcCtD
Boceprevir—Arthralgia—Epirubicin—prostate cancer	2.08e-05	0.000123	CcSEcCtD
Boceprevir—Agitation—Doxorubicin—prostate cancer	2.08e-05	0.000123	CcSEcCtD
Boceprevir—Anxiety—Epirubicin—prostate cancer	2.07e-05	0.000123	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.07e-05	0.000122	CcSEcCtD
Boceprevir—Discomfort—Epirubicin—prostate cancer	2.06e-05	0.000122	CcSEcCtD
Boceprevir—Asthenia—Capecitabine—prostate cancer	2.06e-05	0.000121	CcSEcCtD
Boceprevir—Malaise—Doxorubicin—prostate cancer	2.04e-05	0.000121	CcSEcCtD
Boceprevir—Dry mouth—Epirubicin—prostate cancer	2.04e-05	0.00012	CcSEcCtD
Boceprevir—Vertigo—Doxorubicin—prostate cancer	2.03e-05	0.00012	CcSEcCtD
Boceprevir—Syncope—Doxorubicin—prostate cancer	2.03e-05	0.00012	CcSEcCtD
Boceprevir—Urticaria—Prednisone—prostate cancer	2.03e-05	0.00012	CcSEcCtD
Boceprevir—Pruritus—Capecitabine—prostate cancer	2.03e-05	0.00012	CcSEcCtD
Boceprevir—Leukopenia—Doxorubicin—prostate cancer	2.03e-05	0.00012	CcSEcCtD
Boceprevir—Diarrhoea—Docetaxel—prostate cancer	2.02e-05	0.00012	CcSEcCtD
Boceprevir—Abdominal pain—Prednisone—prostate cancer	2.02e-05	0.000119	CcSEcCtD
Boceprevir—Body temperature increased—Prednisone—prostate cancer	2.02e-05	0.000119	CcSEcCtD
Boceprevir—Confusional state—Epirubicin—prostate cancer	2.01e-05	0.000119	CcSEcCtD
Boceprevir—Palpitations—Doxorubicin—prostate cancer	2e-05	0.000118	CcSEcCtD
Boceprevir—Loss of consciousness—Doxorubicin—prostate cancer	1.99e-05	0.000117	CcSEcCtD
Boceprevir—Infection—Epirubicin—prostate cancer	1.98e-05	0.000117	CcSEcCtD
Boceprevir—Cough—Doxorubicin—prostate cancer	1.97e-05	0.000117	CcSEcCtD
Boceprevir—Shock—Epirubicin—prostate cancer	1.96e-05	0.000116	CcSEcCtD
Boceprevir—Diarrhoea—Capecitabine—prostate cancer	1.96e-05	0.000116	CcSEcCtD
Boceprevir—Nervous system disorder—Epirubicin—prostate cancer	1.96e-05	0.000116	CcSEcCtD
Boceprevir—Dizziness—Docetaxel—prostate cancer	1.96e-05	0.000116	CcSEcCtD
Boceprevir—Thrombocytopenia—Epirubicin—prostate cancer	1.95e-05	0.000115	CcSEcCtD
Boceprevir—Hypertension—Doxorubicin—prostate cancer	1.95e-05	0.000115	CcSEcCtD
Boceprevir—Tachycardia—Epirubicin—prostate cancer	1.95e-05	0.000115	CcSEcCtD
Boceprevir—Skin disorder—Epirubicin—prostate cancer	1.94e-05	0.000115	CcSEcCtD
Boceprevir—Hyperhidrosis—Epirubicin—prostate cancer	1.93e-05	0.000114	CcSEcCtD
Boceprevir—Myalgia—Doxorubicin—prostate cancer	1.93e-05	0.000114	CcSEcCtD
Boceprevir—Arthralgia—Doxorubicin—prostate cancer	1.93e-05	0.000114	CcSEcCtD
Boceprevir—Chest pain—Doxorubicin—prostate cancer	1.93e-05	0.000114	CcSEcCtD
Boceprevir—Anxiety—Doxorubicin—prostate cancer	1.92e-05	0.000113	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	1.91e-05	0.000113	CcSEcCtD
Boceprevir—Discomfort—Doxorubicin—prostate cancer	1.9e-05	0.000112	CcSEcCtD
Boceprevir—Dizziness—Capecitabine—prostate cancer	1.89e-05	0.000112	CcSEcCtD
Boceprevir—Dry mouth—Doxorubicin—prostate cancer	1.88e-05	0.000111	CcSEcCtD
Boceprevir—Vomiting—Docetaxel—prostate cancer	1.88e-05	0.000111	CcSEcCtD
Boceprevir—Hypersensitivity—Prednisone—prostate cancer	1.88e-05	0.000111	CcSEcCtD
Boceprevir—Rash—Docetaxel—prostate cancer	1.87e-05	0.00011	CcSEcCtD
Boceprevir—Hypotension—Epirubicin—prostate cancer	1.87e-05	0.00011	CcSEcCtD
Boceprevir—Dermatitis—Docetaxel—prostate cancer	1.86e-05	0.00011	CcSEcCtD
Boceprevir—Confusional state—Doxorubicin—prostate cancer	1.86e-05	0.00011	CcSEcCtD
Boceprevir—Headache—Docetaxel—prostate cancer	1.85e-05	0.00011	CcSEcCtD
Boceprevir—Infection—Doxorubicin—prostate cancer	1.83e-05	0.000108	CcSEcCtD
Boceprevir—Asthenia—Prednisone—prostate cancer	1.83e-05	0.000108	CcSEcCtD
Boceprevir—Vomiting—Capecitabine—prostate cancer	1.82e-05	0.000108	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Epirubicin—prostate cancer	1.82e-05	0.000107	CcSEcCtD
Boceprevir—Shock—Doxorubicin—prostate cancer	1.82e-05	0.000107	CcSEcCtD
Boceprevir—Nervous system disorder—Doxorubicin—prostate cancer	1.81e-05	0.000107	CcSEcCtD
Boceprevir—Thrombocytopenia—Doxorubicin—prostate cancer	1.81e-05	0.000107	CcSEcCtD
Boceprevir—Rash—Capecitabine—prostate cancer	1.81e-05	0.000107	CcSEcCtD
Boceprevir—Pruritus—Prednisone—prostate cancer	1.81e-05	0.000107	CcSEcCtD
Boceprevir—Insomnia—Epirubicin—prostate cancer	1.81e-05	0.000107	CcSEcCtD
Boceprevir—Dermatitis—Capecitabine—prostate cancer	1.8e-05	0.000107	CcSEcCtD
Boceprevir—Tachycardia—Doxorubicin—prostate cancer	1.8e-05	0.000106	CcSEcCtD
Boceprevir—Headache—Capecitabine—prostate cancer	1.79e-05	0.000106	CcSEcCtD
Boceprevir—Skin disorder—Doxorubicin—prostate cancer	1.79e-05	0.000106	CcSEcCtD
Boceprevir—Paraesthesia—Epirubicin—prostate cancer	1.79e-05	0.000106	CcSEcCtD
Boceprevir—Hyperhidrosis—Doxorubicin—prostate cancer	1.79e-05	0.000105	CcSEcCtD
Boceprevir—Dyspnoea—Epirubicin—prostate cancer	1.78e-05	0.000105	CcSEcCtD
Boceprevir—Nausea—Docetaxel—prostate cancer	1.76e-05	0.000104	CcSEcCtD
Boceprevir—Dyspepsia—Epirubicin—prostate cancer	1.76e-05	0.000104	CcSEcCtD
Boceprevir—Diarrhoea—Prednisone—prostate cancer	1.75e-05	0.000103	CcSEcCtD
Boceprevir—Decreased appetite—Epirubicin—prostate cancer	1.74e-05	0.000102	CcSEcCtD
Boceprevir—Hypotension—Doxorubicin—prostate cancer	1.73e-05	0.000102	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Epirubicin—prostate cancer	1.72e-05	0.000102	CcSEcCtD
Boceprevir—Fatigue—Epirubicin—prostate cancer	1.72e-05	0.000102	CcSEcCtD
Boceprevir—Constipation—Epirubicin—prostate cancer	1.71e-05	0.000101	CcSEcCtD
Boceprevir—Pain—Epirubicin—prostate cancer	1.71e-05	0.000101	CcSEcCtD
Boceprevir—Nausea—Capecitabine—prostate cancer	1.7e-05	0.000101	CcSEcCtD
Boceprevir—Dizziness—Prednisone—prostate cancer	1.69e-05	9.97e-05	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.68e-05	9.94e-05	CcSEcCtD
Boceprevir—Insomnia—Doxorubicin—prostate cancer	1.67e-05	9.87e-05	CcSEcCtD
Boceprevir—Paraesthesia—Doxorubicin—prostate cancer	1.66e-05	9.8e-05	CcSEcCtD
Boceprevir—Dyspnoea—Doxorubicin—prostate cancer	1.65e-05	9.73e-05	CcSEcCtD
Boceprevir—Feeling abnormal—Epirubicin—prostate cancer	1.64e-05	9.72e-05	CcSEcCtD
Boceprevir—Gastrointestinal pain—Epirubicin—prostate cancer	1.63e-05	9.64e-05	CcSEcCtD
Boceprevir—Dyspepsia—Doxorubicin—prostate cancer	1.63e-05	9.6e-05	CcSEcCtD
Boceprevir—Vomiting—Prednisone—prostate cancer	1.62e-05	9.59e-05	CcSEcCtD
Boceprevir—Rash—Prednisone—prostate cancer	1.61e-05	9.51e-05	CcSEcCtD
Boceprevir—Dermatitis—Prednisone—prostate cancer	1.61e-05	9.5e-05	CcSEcCtD
Boceprevir—Decreased appetite—Doxorubicin—prostate cancer	1.61e-05	9.48e-05	CcSEcCtD
Boceprevir—Headache—Prednisone—prostate cancer	1.6e-05	9.44e-05	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.59e-05	9.42e-05	CcSEcCtD
Boceprevir—Fatigue—Doxorubicin—prostate cancer	1.59e-05	9.41e-05	CcSEcCtD
Boceprevir—Urticaria—Epirubicin—prostate cancer	1.59e-05	9.37e-05	CcSEcCtD
Boceprevir—Pain—Doxorubicin—prostate cancer	1.58e-05	9.33e-05	CcSEcCtD
Boceprevir—Constipation—Doxorubicin—prostate cancer	1.58e-05	9.33e-05	CcSEcCtD
Boceprevir—Abdominal pain—Epirubicin—prostate cancer	1.58e-05	9.32e-05	CcSEcCtD
Boceprevir—Body temperature increased—Epirubicin—prostate cancer	1.58e-05	9.32e-05	CcSEcCtD
Boceprevir—Feeling abnormal—Doxorubicin—prostate cancer	1.52e-05	8.99e-05	CcSEcCtD
Boceprevir—Nausea—Prednisone—prostate cancer	1.52e-05	8.95e-05	CcSEcCtD
Boceprevir—Gastrointestinal pain—Doxorubicin—prostate cancer	1.51e-05	8.92e-05	CcSEcCtD
Boceprevir—Hypersensitivity—Epirubicin—prostate cancer	1.47e-05	8.69e-05	CcSEcCtD
Boceprevir—Urticaria—Doxorubicin—prostate cancer	1.47e-05	8.67e-05	CcSEcCtD
Boceprevir—Abdominal pain—Doxorubicin—prostate cancer	1.46e-05	8.62e-05	CcSEcCtD
Boceprevir—Body temperature increased—Doxorubicin—prostate cancer	1.46e-05	8.62e-05	CcSEcCtD
Boceprevir—Asthenia—Epirubicin—prostate cancer	1.43e-05	8.46e-05	CcSEcCtD
Boceprevir—Pruritus—Epirubicin—prostate cancer	1.41e-05	8.34e-05	CcSEcCtD
Boceprevir—Diarrhoea—Epirubicin—prostate cancer	1.37e-05	8.07e-05	CcSEcCtD
Boceprevir—Hypersensitivity—Doxorubicin—prostate cancer	1.36e-05	8.04e-05	CcSEcCtD
Boceprevir—Asthenia—Doxorubicin—prostate cancer	1.33e-05	7.83e-05	CcSEcCtD
Boceprevir—Dizziness—Epirubicin—prostate cancer	1.32e-05	7.8e-05	CcSEcCtD
Boceprevir—Pruritus—Doxorubicin—prostate cancer	1.31e-05	7.72e-05	CcSEcCtD
Boceprevir—Vomiting—Epirubicin—prostate cancer	1.27e-05	7.5e-05	CcSEcCtD
Boceprevir—Diarrhoea—Doxorubicin—prostate cancer	1.26e-05	7.46e-05	CcSEcCtD
Boceprevir—Rash—Epirubicin—prostate cancer	1.26e-05	7.43e-05	CcSEcCtD
Boceprevir—Dermatitis—Epirubicin—prostate cancer	1.26e-05	7.43e-05	CcSEcCtD
Boceprevir—Headache—Epirubicin—prostate cancer	1.25e-05	7.39e-05	CcSEcCtD
Boceprevir—Dizziness—Doxorubicin—prostate cancer	1.22e-05	7.21e-05	CcSEcCtD
Boceprevir—Nausea—Epirubicin—prostate cancer	1.19e-05	7e-05	CcSEcCtD
Boceprevir—Vomiting—Doxorubicin—prostate cancer	1.17e-05	6.94e-05	CcSEcCtD
Boceprevir—Rash—Doxorubicin—prostate cancer	1.16e-05	6.88e-05	CcSEcCtD
Boceprevir—Dermatitis—Doxorubicin—prostate cancer	1.16e-05	6.87e-05	CcSEcCtD
Boceprevir—Headache—Doxorubicin—prostate cancer	1.16e-05	6.83e-05	CcSEcCtD
Boceprevir—Nausea—Doxorubicin—prostate cancer	1.1e-05	6.48e-05	CcSEcCtD
Boceprevir—CYP3A4—Metabolism—GRHL1—prostate cancer	4.66e-06	3.45e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ADI1—prostate cancer	4.66e-06	3.45e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	4.65e-06	3.44e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PIK3CA—prostate cancer	4.62e-06	3.42e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTA1—prostate cancer	4.6e-06	3.41e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	4.6e-06	3.41e-05	CbGpPWpGaD
Boceprevir—CTSK—Immune System—AKT1—prostate cancer	4.58e-06	3.39e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTO1—prostate cancer	4.55e-06	3.37e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HSD3B2—prostate cancer	4.55e-06	3.37e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NAT2—prostate cancer	4.55e-06	3.37e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HSD17B3—prostate cancer	4.53e-06	3.36e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ACSL4—prostate cancer	4.53e-06	3.36e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	4.5e-06	3.33e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	4.49e-06	3.32e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—KRAS—prostate cancer	4.43e-06	3.28e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP2C18—prostate cancer	4.37e-06	3.23e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—LRP2—prostate cancer	4.37e-06	3.23e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PLCB2—prostate cancer	4.37e-06	3.23e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ARG2—prostate cancer	4.35e-06	3.22e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PHGDH—prostate cancer	4.35e-06	3.22e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—UMPS—prostate cancer	4.35e-06	3.22e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GRHPR—prostate cancer	4.33e-06	3.21e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—UGT2B17—prostate cancer	4.33e-06	3.21e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CKMT2—prostate cancer	4.33e-06	3.21e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—UGT2B15—prostate cancer	4.33e-06	3.21e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—NCOA1—prostate cancer	4.32e-06	3.2e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—P4HB—prostate cancer	4.28e-06	3.17e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	4.28e-06	3.17e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—LDHB—prostate cancer	4.26e-06	3.15e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP3A5—prostate cancer	4.18e-06	3.1e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SLC22A1—prostate cancer	4.16e-06	3.08e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	4.16e-06	3.08e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—RXRA—prostate cancer	4.11e-06	3.04e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL6—prostate cancer	4.09e-06	3.03e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—MBTPS1—prostate cancer	4.08e-06	3.02e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—RFK—prostate cancer	4.08e-06	3.02e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTM3—prostate cancer	4.08e-06	3.02e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NAGLU—prostate cancer	4.08e-06	3.02e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SULT2B1—prostate cancer	4.08e-06	3.02e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AOX1—prostate cancer	4.08e-06	3.02e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PGAM2—prostate cancer	4.08e-06	3.02e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PIK3CA—prostate cancer	4.07e-06	3.01e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SULT2A1—prostate cancer	4.06e-06	3e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	4.05e-06	3e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PDHA1—prostate cancer	4.04e-06	2.99e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTA3—prostate cancer	4.04e-06	2.99e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—UCP3—prostate cancer	4.04e-06	2.99e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—TCN2—prostate cancer	4.04e-06	2.99e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—MED12—prostate cancer	3.99e-06	2.95e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GNG5—prostate cancer	3.96e-06	2.93e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TP53—prostate cancer	3.94e-06	2.91e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP3A43—prostate cancer	3.86e-06	2.86e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AMACR—prostate cancer	3.86e-06	2.86e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—DEGS1—prostate cancer	3.86e-06	2.86e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NAT1—prostate cancer	3.86e-06	2.86e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SRD5A2—prostate cancer	3.86e-06	2.86e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HSD3B1—prostate cancer	3.85e-06	2.85e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC22A3—prostate cancer	3.85e-06	2.85e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NCOA3—prostate cancer	3.82e-06	2.82e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—AKT1—prostate cancer	3.77e-06	2.79e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	3.73e-06	2.76e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	3.72e-06	2.75e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTA4—prostate cancer	3.7e-06	2.74e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—TBXAS1—prostate cancer	3.7e-06	2.74e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HSD17B1—prostate cancer	3.69e-06	2.73e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	3.65e-06	2.7e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HPGDS—prostate cancer	3.64e-06	2.69e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP2C19—prostate cancer	3.62e-06	2.68e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL6—prostate cancer	3.6e-06	2.67e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTA2—prostate cancer	3.6e-06	2.67e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ABCG5—prostate cancer	3.56e-06	2.63e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SULT1A1—prostate cancer	3.56e-06	2.63e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ACHE—prostate cancer	3.53e-06	2.61e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTT1—prostate cancer	3.53e-06	2.61e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP2A6—prostate cancer	3.49e-06	2.58e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTA1—prostate cancer	3.47e-06	2.57e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	3.44e-06	2.55e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTO1—prostate cancer	3.44e-06	2.54e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NAT2—prostate cancer	3.44e-06	2.54e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HSD3B2—prostate cancer	3.44e-06	2.54e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AKR1C3—prostate cancer	3.39e-06	2.51e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PRKACB—prostate cancer	3.38e-06	2.5e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP17A1—prostate cancer	3.34e-06	2.47e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AKT1—prostate cancer	3.32e-06	2.46e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP2C18—prostate cancer	3.29e-06	2.44e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—LRP2—prostate cancer	3.29e-06	2.44e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PLCB2—prostate cancer	3.29e-06	2.44e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HPGD—prostate cancer	3.28e-06	2.43e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—B4GALT4—prostate cancer	3.28e-06	2.43e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—P4HB—prostate cancer	3.23e-06	2.39e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NCOA2—prostate cancer	3.18e-06	2.36e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	3.16e-06	2.34e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC22A1—prostate cancer	3.14e-06	2.33e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—PPARA—prostate cancer	3.14e-06	2.32e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—TNFRSF21—prostate cancer	3.09e-06	2.29e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SULT2A1—prostate cancer	3.06e-06	2.27e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	3.06e-06	2.27e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SLC5A5—prostate cancer	3.04e-06	2.25e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—MED12—prostate cancer	3.01e-06	2.23e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP7B1—prostate cancer	3e-06	2.22e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—MTAP—prostate cancer	3e-06	2.22e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GNG5—prostate cancer	2.99e-06	2.21e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP2E1—prostate cancer	2.97e-06	2.2e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NQO1—prostate cancer	2.93e-06	2.17e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SULT1E1—prostate cancer	2.93e-06	2.17e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SRD5A1—prostate cancer	2.93e-06	2.17e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—TH—prostate cancer	2.89e-06	2.14e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NCOA3—prostate cancer	2.88e-06	2.13e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP3A4—prostate cancer	2.86e-06	2.12e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP1B1—prostate cancer	2.81e-06	2.08e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ACSL4—prostate cancer	2.79e-06	2.07e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HSD17B3—prostate cancer	2.79e-06	2.07e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HPGDS—prostate cancer	2.75e-06	2.03e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP2C19—prostate cancer	2.73e-06	2.02e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GGT1—prostate cancer	2.72e-06	2.02e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NCOA1—prostate cancer	2.68e-06	1.99e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—UMPS—prostate cancer	2.68e-06	1.98e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PHGDH—prostate cancer	2.68e-06	1.98e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ARG2—prostate cancer	2.68e-06	1.98e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTT1—prostate cancer	2.66e-06	1.97e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ACHE—prostate cancer	2.66e-06	1.97e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP19A1—prostate cancer	2.64e-06	1.96e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP2A6—prostate cancer	2.63e-06	1.95e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—LDHB—prostate cancer	2.63e-06	1.94e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	2.59e-06	1.91e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP3A5—prostate cancer	2.58e-06	1.91e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AKR1C3—prostate cancer	2.56e-06	1.9e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—RXRA—prostate cancer	2.55e-06	1.89e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PRKACB—prostate cancer	2.55e-06	1.89e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP17A1—prostate cancer	2.52e-06	1.87e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.49e-06	1.85e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTA3—prostate cancer	2.49e-06	1.84e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PDHA1—prostate cancer	2.49e-06	1.84e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—UCP3—prostate cancer	2.49e-06	1.84e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—TCN2—prostate cancer	2.49e-06	1.84e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—COMT—prostate cancer	2.46e-06	1.82e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTP1—prostate cancer	2.45e-06	1.81e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ITPR1—prostate cancer	2.41e-06	1.78e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NCOA2—prostate cancer	2.4e-06	1.78e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HSD3B1—prostate cancer	2.37e-06	1.76e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC22A3—prostate cancer	2.37e-06	1.76e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC5A5—prostate cancer	2.29e-06	1.7e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTA4—prostate cancer	2.28e-06	1.69e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—TBXAS1—prostate cancer	2.28e-06	1.69e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—TYMS—prostate cancer	2.28e-06	1.68e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTM1—prostate cancer	2.25e-06	1.66e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP2E1—prostate cancer	2.24e-06	1.66e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTA2—prostate cancer	2.22e-06	1.64e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NQO1—prostate cancer	2.21e-06	1.64e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—LPL—prostate cancer	2.21e-06	1.63e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SULT1A1—prostate cancer	2.19e-06	1.62e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ABCG5—prostate cancer	2.19e-06	1.62e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—TH—prostate cancer	2.18e-06	1.61e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP3A4—prostate cancer	2.16e-06	1.6e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTA1—prostate cancer	2.14e-06	1.58e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP1A1—prostate cancer	2.13e-06	1.58e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP1B1—prostate cancer	2.12e-06	1.57e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.12e-06	1.57e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTO1—prostate cancer	2.12e-06	1.57e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NAT2—prostate cancer	2.12e-06	1.57e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ERCC2—prostate cancer	2.11e-06	1.56e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GGT1—prostate cancer	2.06e-06	1.52e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—LRP2—prostate cancer	2.03e-06	1.5e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.03e-06	1.5e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PLCB2—prostate cancer	2.03e-06	1.5e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NCOA1—prostate cancer	2.02e-06	1.5e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP19A1—prostate cancer	2e-06	1.48e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—P4HB—prostate cancer	1.99e-06	1.47e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—MTHFR—prostate cancer	1.99e-06	1.47e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PPARA—prostate cancer	1.95e-06	1.44e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.94e-06	1.43e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—RXRA—prostate cancer	1.93e-06	1.43e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.89e-06	1.4e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—MED12—prostate cancer	1.86e-06	1.37e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—COMT—prostate cancer	1.86e-06	1.37e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTP1—prostate cancer	1.85e-06	1.37e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GNG5—prostate cancer	1.84e-06	1.36e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CAV1—prostate cancer	1.83e-06	1.36e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ITPR1—prostate cancer	1.82e-06	1.34e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NCOA3—prostate cancer	1.77e-06	1.31e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—TYMS—prostate cancer	1.72e-06	1.27e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTM1—prostate cancer	1.7e-06	1.26e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HPGDS—prostate cancer	1.69e-06	1.25e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.68e-06	1.24e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CG—prostate cancer	1.67e-06	1.24e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—LPL—prostate cancer	1.67e-06	1.23e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTT1—prostate cancer	1.64e-06	1.21e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ACHE—prostate cancer	1.64e-06	1.21e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.62e-06	1.2e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP1A1—prostate cancer	1.61e-06	1.19e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ERCC2—prostate cancer	1.6e-06	1.18e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—INS—prostate cancer	1.58e-06	1.17e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.58e-06	1.17e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PRKACB—prostate cancer	1.57e-06	1.16e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.55e-06	1.15e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CREBBP—prostate cancer	1.55e-06	1.15e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—MTHFR—prostate cancer	1.5e-06	1.11e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NCOA2—prostate cancer	1.48e-06	1.1e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PPARA—prostate cancer	1.47e-06	1.09e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CD—prostate cancer	1.47e-06	1.09e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.41e-06	1.05e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NOS3—prostate cancer	1.39e-06	1.03e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CAV1—prostate cancer	1.38e-06	1.02e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.38e-06	1.02e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NQO1—prostate cancer	1.36e-06	1.01e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—TH—prostate cancer	1.34e-06	9.95e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.31e-06	9.68e-06	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CB—prostate cancer	1.28e-06	9.47e-06	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTGS2—prostate cancer	1.27e-06	9.38e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GGT1—prostate cancer	1.27e-06	9.37e-06	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CG—prostate cancer	1.26e-06	9.32e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NCOA1—prostate cancer	1.25e-06	9.23e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.23e-06	9.1e-06	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—INS—prostate cancer	1.19e-06	8.83e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—RXRA—prostate cancer	1.19e-06	8.78e-06	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CREBBP—prostate cancer	1.17e-06	8.65e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—COMT—prostate cancer	1.14e-06	8.46e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTP1—prostate cancer	1.14e-06	8.42e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ITPR1—prostate cancer	1.12e-06	8.28e-06	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CD—prostate cancer	1.11e-06	8.2e-06	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTEN—prostate cancer	1.11e-06	8.18e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—TYMS—prostate cancer	1.06e-06	7.83e-06	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—EP300—prostate cancer	1.05e-06	7.8e-06	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NOS3—prostate cancer	1.05e-06	7.74e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTM1—prostate cancer	1.05e-06	7.74e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—LPL—prostate cancer	1.03e-06	7.59e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP1A1—prostate cancer	9.91e-07	7.33e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ERCC2—prostate cancer	9.83e-07	7.27e-06	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CB—prostate cancer	9.66e-07	7.15e-06	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTGS2—prostate cancer	9.57e-07	7.08e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—MTHFR—prostate cancer	9.24e-07	6.84e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPARA—prostate cancer	9.06e-07	6.71e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CAV1—prostate cancer	8.52e-07	6.31e-06	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTEN—prostate cancer	8.34e-07	6.17e-06	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—EP300—prostate cancer	7.96e-07	5.89e-06	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CA—prostate cancer	7.8e-07	5.77e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CG—prostate cancer	7.76e-07	5.75e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—INS—prostate cancer	7.35e-07	5.44e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CREBBP—prostate cancer	7.2e-07	5.33e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CD—prostate cancer	6.82e-07	5.05e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NOS3—prostate cancer	6.44e-07	4.77e-06	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AKT1—prostate cancer	6.37e-07	4.72e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CB—prostate cancer	5.95e-07	4.4e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTGS2—prostate cancer	5.89e-07	4.36e-06	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CA—prostate cancer	5.89e-07	4.36e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTEN—prostate cancer	5.14e-07	3.8e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—EP300—prostate cancer	4.9e-07	3.63e-06	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AKT1—prostate cancer	4.81e-07	3.56e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CA—prostate cancer	3.63e-07	2.68e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AKT1—prostate cancer	2.96e-07	2.19e-06	CbGpPWpGaD
